Mean platelet volume, thrombocytosis, and survival in non-small cell lung cancer patients treated with first-line pembrolizumab alone or with chemotherapy was published today in Cancer immunology, immunotherapy : CII.
UPDATES
UPDATES
Mean platelet volume, thrombocytosis, and survival in non-small cell lung cancer patients treated with first-line pembrolizumab alone or with chemotherapy was published today in Cancer immunology, immunotherapy : CII.